The chemotherapy-induced myelosuppression treatments market share is expected to increase from its present size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028, with a cumulative annual growth rate (CAGR) of 3.3%. The Chemotherapy-Induced Treatment Market plays a vital role in the comprehensive care of cancer patients, addressing the often debilitating side …
Tag Archives: Chemotherapy-Induced Treatment Market Forecast
Chemotherapy-Induced Treatment Market Envisions a Steady 3.2% CAGR Journey Through 2028-FMI Projection
With a 3.3% cumulative annual growth rate (CAGR), the chemotherapy-induced myelosuppression treatments market is predicted to rise from its current size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028. A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in …